000 01577 a2200385 4500
005 20250514074447.0
264 0 _c20031117
008 200311s 0 0 eng d
022 _a0931-0509
024 7 _a10.1093/ndt/gfg238
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVuong, Thi Danh
245 0 0 _aHypoalbuminaemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine.
_h[electronic resource]
260 _bNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
_cAug 2003
300 _a1485-92 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHypoalbuminemia
_xphysiopathology
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLysophosphatidylcholines
_xpharmacology
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRegional Blood Flow
_xdrug effects
650 0 4 _aVasoconstrictor Agents
_xpharmacology
700 1 _aBraam, Branko
700 1 _aWillekes-Koolschijn, Nel
700 1 _aBoer, Peter
700 1 _aKoomans, Hein A
700 1 _aJoles, Jaap A
773 0 _tNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
_gvol. 18
_gno. 8
_gp. 1485-92
856 4 0 _uhttps://doi.org/10.1093/ndt/gfg238
_zAvailable from publisher's website
999 _c12672412
_d12672412